FDA Approves Unknown Drug — QUAGEN

QUAGEN has received federal approval for ANDA213892, likely allowing the company to introduce a generic version of the recently approved July 7th product. This expansion of the company's portfolio is expected to support revenue growth and intensify market competition in its target therapeutic space.